REVIEW
|
doi:10.20944/preprints202311.0259.v1
Subject:
Medicine And Pharmacology,
Dermatology
Keywords:
psoriasis; PDE4 inhibitor; apremilast; roflumilast; crisaborole; clinical trials; review
Online: 6 November 2023 (07:07:05 CET)